세계의 생화학적 방어 시장 보고서(2025년)

Biochemical defense is the natural or engineered mechanisms through which living organisms produce chemical substances, such as toxins, enzymes, or antimicrobial compounds, to protect against predators, pathogens, or environmental stress. Its primary function is to neutralize or inhibit harmful agents, ensuring survival and maintaining physiological balance.

The key product types of biochemical defense include antibiotics, vaccines, antivirals, enzymes, and monoclonal antibodies. Antibiotics are pharmaceutical drugs used to prevent or treat bacterial infections by killing bacteria or inhibiting their growth, supporting recovery, reducing infection severity, and restoring health. They act through various modes such as mechanism-based therapy, targeted therapy, immunotherapy, gene therapy, and protein-based therapy, and are applied across medical conditions including infectious diseases, cancer, autoimmune disorders, neurological diseases, and cardiovascular diseases. These products are distributed via direct sales, distributors, online platforms, pharmacies, and hospital pharmacies, serving end users such as hospitals, research laboratories, pharmaceutical companies, diagnostic centers, and academic institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp hike in U.S. tariffs and the associated trade disputes in spring 2025 are notably impacting the aerospace and defense sector by raising costs for titanium, carbon fiber composites, and avionics materials largely sourced from global suppliers. Defense contractors, locked into fixed-price government contracts, absorb these added costs, while commercial aerospace firms face airline pushback on higher aircraft prices. Delays in component shipments due to customs bottlenecks further disrupt tight production schedules for jets and satellites. The industry is responding by stockpiling critical materials, seeking waivers for defense-related imports, and collaborating with allied nations to diversify supply chain.

The biochemical defense market research report is one of a series of new reports from The Business Research Company that provides biochemical defense market statistics, including biochemical defense industry global market size, regional shares, competitors with a biochemical defense market share, detailed biochemical defense market segments, market trends and opportunities, and any further data you may need to thrive in the biochemical defense industry. This biochemical defense market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biochemical defense market size has grown strongly in recent years. It will grow from $11.31 billion in 2024 to $12 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historical period can be attributed to increasing risks of cross-border biological smuggling, a rise in accidental laboratory pathogen releases, escalating geopolitical bio-warfare tensions, growing concerns over dual-use biotechnology, and heightened exposure to environmental toxins.

The biochemical defense market size is expected to see strong growth in the next few years. It will grow to $15.37 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth during the forecast period is driven by increasing government funding for biodefense programs, rising threats of bioterrorism and chemical warfare, growing international conflicts, increasing investments in advanced detection and monitoring technologies, and rising demand for protective equipment and rapid response systems. Primary trends in the forecast period include the development of next-generation vaccines, advancement in portable diagnostic kits, integration of genomics with defense strategies, incorporation of military and civilian bio-defense systems, and innovation in bio-decontamination materials.

Climate change increasing pathogen spread is expected to enhance the growth of the biochemical defense market in the coming years. Climate change increasing pathogen spread refers to how rising temperatures, changing rainfall patterns, and extreme weather events create conditions that allow disease causing organisms such as mosquitoes, ticks, bacteria, and fungi to survive, multiply, and expand into new regions. The spread of pathogens is intensifying due to rising global temperatures, altered rainfall, extreme weather, and shifting ecosystems. Biochemical defense systems address this growing threat by enabling early detection, rapid response, and containment of emerging pathogens, while also strengthening public health systems and supporting the development of vaccines. For example, in October 2023, according to the World Health Organization, a Switzerland based specialized agency of the United Nations, by the 2030s, climate change could result in an additional 250,000 deaths annually from diseases such as malaria and the effects of coastal flooding, threatening decades of progress in global health, development, and poverty reduction, while worsening health inequalities. Therefore, climate change increasing pathogen spread is enhancing the growth of the biochemical defense market.

Leading companies operating in the biochemical defense market are emphasizing the development of advanced technologies, such as supercomputing systems, to accelerate pathogen analysis and strengthen rapid response capabilities. A supercomputing system is a high-performance computational platform designed to process vast amounts of biological and chemical data at exceptional speeds, enabling quicker pathogen identification and the formulation of defense strategies. For example, in August 2024, the United States Department of Defense, in collaboration with the National Nuclear Security Administration, launched a dedicated biological defense supercomputer at the Lawrence Livermore National Laboratory (LLNL) in California. This cutting-edge system supports large-scale simulations and AI-driven modeling to advance biosurveillance, threat detection, materials research, and medical countermeasure development. It also integrates a rapid-response laboratory for AI-assisted drug discovery and protein engineering, drastically reducing the time required for developing and testing biological defenses-from weeks to mere days or hours.

In April 2024, Ginkgo Bioworks Holdings Inc., a US-based biotech company, acquired the platform assets of AgBiome Inc. for an undisclosed amount. Through this acquisition, Ginkgo Bioworks aims to expand its agricultural biological discovery and development platform by integrating AgBiome's microbial strain library, gene sequences, and validated product pipeline, accelerating innovation and delivering advanced solutions for sustainable agriculture. AgBiome Inc. is a US-based biotechnology company specializing in biochemical defense.

Major players operating in the biochemical defense market are Emergent BioSolutions Inc., Thermo Fisher Scientific Inc., SIGA Technologies Inc., Bavarian Nordic A/S, Dynavax Technologies Inc., Cleveland BioLabs, Inc., Soligenix Inc., GlaxoSmithKline plc, Elusys Therapeutics Inc., General Dynamics Corporation (Dynport Vaccine Company LLC), EPIVAX Inc., Rheinmetall AG, Zeteo Tech LLC, MSA Safety Incorporated, Ichor Medical Systems, BioFire Defense LLC, Smiths Detection Group Ltd., Tonix Pharmaceuticals Holding Corp., AirBoss Defense Group Inc., Aeolus Pharmaceuticals

North America was the largest region in the biochemical defense market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochemical defense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biochemical defense Market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biochemical defense market consists of revenues earned by entities by providing services such as detection and monitoring, decontamination services, consulting and risk assessment, training and simulation, and protective equipment provision. The market value includes the value of related goods sold by the service provider or included within the service offering. The biochemical defense market also includes sales of personal protective equipment, decontamination agents, biosensors, immunoglobulins, and diagnostic kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biochemical Defense Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biochemical defense market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biochemical defense ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biochemical defense market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Antibiotics; Vaccines; Antivirals; Enzymes; Monoclonal Antibodies.
• 2) By Mode of Action: Mechanism-Based; Targeted Therapy; Immunotherapy; Gene Therapy; Protein-Based Therapy
• 3) By Application: Infectious Diseases; Cancer Treatment; Autoimmune Disorders; Neurological Diseases; Cardiovascular Diseases
• 4) By Distribution Channel: Direct Sales; Distributors; Online Sales; Pharmacies; Hospital Pharmacy
• 5) By End-User: Hospitals; Research Laboratories; Pharmaceutical Companies; Diagnostics Centers; Academic Institutions
• Subsegments:
• 1) By Antibiotics: Penicillin; Tetracycline; Cephalosporins; Macrolides; Aminoglycosides
• 2) By Vaccines: Live Attenuated Vaccines; Inactivated Vaccines; Subunit Vaccines; Conjugate Vaccines; Messenger Ribonucleic Acid Vaccines
• 3) By Antivirals: Protease Inhibitors; Reverse Transcriptase Inhibitors; Neuraminidase Inhibitors; Polymerase Inhibitors; Fusion Inhibitors
• 4) By Enzymes: Proteases; Lipases; Amylases; Nucleases; Oxidoreductases
• 5) By Monoclonal Antibodies: Humanized Antibodies; Chimeric Antibodies; Murine Antibodies; Bispecific Antibodies; Fully Human Antibodies
• Companies Mentioned: Emergent BioSolutions Inc., Thermo Fisher Scientific Inc., SIGA Technologies Inc., Bavarian Nordic A/S, Dynavax Technologies Inc., Cleveland BioLabs, Inc., Soligenix Inc., GlaxoSmithKline plc, Elusys Therapeutics Inc., General Dynamics Corporation (Dynport Vaccine Company LLC), EPIVAX Inc., Rheinmetall AG, Zeteo Tech LLC, MSA Safety Incorporated, Ichor Medical Systems, BioFire Defense LLC, Smiths Detection Group Ltd., Tonix Pharmaceuticals Holding Corp., AirBoss Defense Group Inc., Aeolus Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biochemical Defense Market Characteristics

3. Biochemical Defense Market Trends And Strategies

4. Biochemical Defense Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biochemical Defense Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biochemical Defense PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biochemical Defense Market Growth Rate Analysis
• 5.4. Global Biochemical Defense Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biochemical Defense Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biochemical Defense Total Addressable Market (TAM)

6. Biochemical Defense Market Segmentation

• 6.1. Global Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Vaccines
• Antivirals
• Enzymes
• Monoclonal Antibodies.
• 6.2. Global Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mechanism-Based
• Targeted Therapy
• Immunotherapy
• Gene Therapy
• Protein-Based Therapy
• 6.3. Global Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Cancer Treatment
• Autoimmune Disorders
• Neurological Diseases
• Cardiovascular Diseases
• 6.4. Global Biochemical Defense Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Sales
• Distributors
• Online Sales
• Pharmacies
• Hospital Pharmacy
• 6.5. Global Biochemical Defense Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Laboratories
• Pharmaceutical Companies
• Diagnostics Centers
• Academic Institutions
• 6.6. Global Biochemical Defense Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Penicillin
• Tetracycline
• Cephalosporins
• Macrolides
• Aminoglycosides
• 6.7. Global Biochemical Defense Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Conjugate Vaccines
• Messenger Ribonucleic Acid Vaccines
• 6.8. Global Biochemical Defense Market, Sub-Segmentation Of Antivirals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protease Inhibitors
• Reverse Transcriptase Inhibitors
• Neuraminidase Inhibitors
• Polymerase Inhibitors
• Fusion Inhibitors
• 6.9. Global Biochemical Defense Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proteases
• Lipases
• Amylases
• Nucleases
• Oxidoreductases
• 6.10. Global Biochemical Defense Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Humanized Antibodies
• Chimeric Antibodies
• Murine Antibodies
• Bispecific Antibodies
• Fully Human Antibodies

7. Biochemical Defense Market Regional And Country Analysis

• 7.1. Global Biochemical Defense Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biochemical Defense Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biochemical Defense Market

• 8.1. Asia-Pacific Biochemical Defense Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biochemical Defense Market

• 9.1. China Biochemical Defense Market Overview
• 9.2. China Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biochemical Defense Market

• 10.1. India Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biochemical Defense Market

• 11.1. Japan Biochemical Defense Market Overview
• 11.2. Japan Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biochemical Defense Market

• 12.1. Australia Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biochemical Defense Market

• 13.1. Indonesia Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biochemical Defense Market

• 14.1. South Korea Biochemical Defense Market Overview
• 14.2. South Korea Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biochemical Defense Market

• 15.1. Western Europe Biochemical Defense Market Overview
• 15.2. Western Europe Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biochemical Defense Market

• 16.1. UK Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biochemical Defense Market

• 17.1. Germany Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biochemical Defense Market

• 18.1. France Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biochemical Defense Market

• 19.1. Italy Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biochemical Defense Market

• 20.1. Spain Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biochemical Defense Market

• 21.1. Eastern Europe Biochemical Defense Market Overview
• 21.2. Eastern Europe Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biochemical Defense Market

• 22.1. Russia Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biochemical Defense Market

• 23.1. North America Biochemical Defense Market Overview
• 23.2. North America Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biochemical Defense Market

• 24.1. USA Biochemical Defense Market Overview
• 24.2. USA Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biochemical Defense Market

• 25.1. Canada Biochemical Defense Market Overview
• 25.2. Canada Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biochemical Defense Market

• 26.1. South America Biochemical Defense Market Overview
• 26.2. South America Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biochemical Defense Market

• 27.1. Brazil Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biochemical Defense Market

• 28.1. Middle East Biochemical Defense Market Overview
• 28.2. Middle East Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biochemical Defense Market

• 29.1. Africa Biochemical Defense Market Overview
• 29.2. Africa Biochemical Defense Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biochemical Defense Market, Segmentation By Mode of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biochemical Defense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biochemical Defense Market Competitive Landscape And Company Profiles

• 30.1. Biochemical Defense Market Competitive Landscape
• 30.2. Biochemical Defense Market Company Profiles
  • 30.2.1. Emergent BioSolutions Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. SIGA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bavarian Nordic A/S Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Dynavax Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Biochemical Defense Market Other Major And Innovative Companies

• 31.1. Cleveland BioLabs Inc.
• 31.2. Soligenix Inc.
• 31.3. GlaxoSmithKline plc
• 31.4. Elusys Therapeutics Inc.
• 31.5. General Dynamics Corporation (Dynport Vaccine Company LLC)
• 31.6. EPIVAX Inc.
• 31.7. Rheinmetall AG
• 31.8. Zeteo Tech LLC
• 31.9. MSA Safety Incorporated
• 31.10. Ichor Medical Systems
• 31.11. BioFire Defense LLC
• 31.12. Smiths Detection Group Ltd.
• 31.13. Tonix Pharmaceuticals Holding Corp.
• 31.14. AirBoss Defense Group Inc.
• 31.15. Aeolus Pharmaceuticals

32. Global Biochemical Defense Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biochemical Defense Market

34. Recent Developments In The Biochemical Defense Market

35. Biochemical Defense Market High Potential Countries, Segments and Strategies

• 35.1 Biochemical Defense Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biochemical Defense Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biochemical Defense Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer